| J9271 | Injection, pembrolizumab, 1 mg | 26,200 | $40 | $1.1M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 3,040 | $100 | $295.2K |
| J0897 | Injection, denosumab, 1 mg | 8,760 | $20 | $157.7K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 65,100 | $1 | $130.2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 940 | $90 | $80.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 640 | $110 | $66.7K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 510 | $60 | $29.2K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 19,500 | $1 | $19.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 150 | $120 | $18.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 270 | $50 | $13.1K |